Ophthalmology Drugs Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：125頁
文件格式：PDF
價 格：
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
Ophthalmology drugs market covers drugs that are used in the treatment of eye related diseases such as refractive errors, cataracts, glaucoma, conjunctivitis, retinal diseases, and macular degeneration. Some of the major drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.
The global ophthalmology drugs market was estimated to be around $26 billion as of 2016. The ophthalmology drugs market market made up around 2.5% of the overall pharmaceuticals market in 2016. The ophthalmology drugs market was the smallest market in the global pharmaceutical market in 2016.
Development Of Combination Therapies
Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the market. For instance, in September 2013, Alcon (a subsidiary of Novartis) received FDA approval for commercialization of its Simbrinza, a fixed dose combination drug without beta blocker used for the treatment of glaucoma.
The global ophthalmology drugs market was estimated to be around $26 billion as of 2016. The ophthalmology drugs market market made up around 2.5% of the overall pharmaceuticals market in 2016. The ophthalmology drugs market was the smallest market in the global pharmaceutical market in 2016.
Development Of Combination Therapies
Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the market. For instance, in September 2013, Alcon (a subsidiary of Novartis) received FDA approval for commercialization of its Simbrinza, a fixed dose combination drug without beta blocker used for the treatment of glaucoma.
1. Ophthalmology Drugs Market Characteristics;
2. Ophthalmology Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Ophthalmology Drugs Market Customer Information;
5. Ophthalmology Drugs Market Segmentation;
5.1. Global Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 5.2. Global Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Ophthalmology Drugs Market Trends And Strategies;
6. Ophthalmology Drugs Market Regional And Country Analysis;
6.1. Global Ophthalmology Drugs Market, 2016, By Region; 6.2. Global Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Ophthalmology Drugs Market, 2016, By Country; 6.4. Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors;
7.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Ophthalmology Drugs Expenditure, Global;
8. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Ophthalmology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Ophthalmology Drugs Expenditure, By Country;
9. Ophthalmology Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Glaucoma, 2014, By Country;
10. Asia-Pacific Ophthalmology Drugs Market;
10.1.1. Asia-Pacific Ophthalmology Drugs Market Overview; 10.1.2. Asia-Pacific Ophthalmology Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.2. Asia-Pacific Ophthalmology Drugs Market: Country Analysis; 10.3. China Ophthalmology Drugs Market; 10.3.1. China Ophthalmology Drugs Market Overview; 10.3.2. China Ophthalmology Drugs Historic Market, 2012 - 2016; 10.3.3. China Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.3.4. China Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.3.5. China Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 10.4. India Ophthalmology Drugs Market; 10.4.1. India Ophthalmology Drugs Market Overview; 10.4.2. India Ophthalmology Drugs Historic Market, 2012 - 2016; 10.4.3. India Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.4.4. India Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.4.5. India Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 10.5. Japan Ophthalmology Drugs Market; 10.5.1. Japan Ophthalmology Drugs Market Overview; 10.5.2. Japan Ophthalmology Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.5.5. Japan Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 10.6. Australia Ophthalmology Drugs Market; 10.6.1. Australia Ophthalmology Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.6.4. Australia Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
11. Western Europe Ophthalmology Drugs Market;
11.1.1. Western Europe Ophthalmology Drugs Market Overview; 11.1.2. Western Europe Ophthalmology Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.2. Western Europe Ophthalmology Drugs Market: Country Analysis; 11.3. UK Ophthalmology Drugs Market; 11.3.1. UK Ophthalmology Drugs Market Overview; 11.3.2. UK Ophthalmology Drugs Historic Market, 2012 - 2016; 11.3.3. UK Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.3.5. UK Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.4. Germany Ophthalmology Drugs Market; 11.4.1. Germany Ophthalmology Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.4.4 Germany Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.5 France Ophthalmology Drugs Market; 11.5.1 France Ophthalmology Drugs Historic Market, 2012 - 2016; 11.5.2 France Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.5.3 France Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.5.4 France Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.6. Italy Ophthalmology Drugs Market; 11.6.1. Italy Ophthalmology Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.6.4. Italy Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.7. Spain Ophthalmology Drugs Market; 11.7.1. Spain Ophthalmology Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.7.4. Spain Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Ophthalmology Drugs Market;
12.1.1. Eastern Europe Ophthalmology Drugs Market Overview; 12.1.2. Eastern Europe Ophthalmology Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Ophthalmology Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.2. Eastern Europe Ophthalmology Drugs Market: Country Analysis; 12.3. Russia Ophthalmology Drugs Market; 12.3.1. Russia Ophthalmology Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Ophthalmology Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.3.4. Russia Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
13. North America Ophthalmology Drugs Market;
13.1.1. North America Ophthalmology Drugs Market Overview; 13.1.2. North America Ophthalmology Drugs Historic Market, 2012 - 2016; 13.1.3. North America Ophthalmology Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.2. North America Ophthalmology Drugs Market: Country Analysis; 13.3. USA Ophthalmology Drugs Market; 13.3.1. USA Ophthalmology Drugs Historic Market, 2012 - 2016; 13.3.2. USA Ophthalmology Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.3.4. USA Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
14. South America Ophthalmology Drugs Market;
14.1.1. South America Ophthalmology Drugs Market Overview; 14.1.2. South America Ophthalmology Drugs Historic Market, 2012 - 2016; 14.1.3. South America Ophthalmology Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.2. South America Ophthalmology Drugs Market: Country Analysis; 14.3. Brazil Ophthalmology Drugs Market; 14.3.1. Brazil Ophthalmology Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Ophthalmology Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.3.4. Brazil Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
15. Middle East Ophthalmology Drugs Market;
15.1.1. Middle East Ophthalmology Drugs Market Overview; 15.1.2. Middle East Ophthalmology Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Ophthalmology Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);
16. Africa Ophthalmology Drugs Market;
16.1.1. Africa Ophthalmology Drugs Market Overview; 16.1.2. Africa Ophthalmology Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Ophthalmology Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);
17. Ophthalmology Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Novartis Ag; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Regeneron; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Allergan; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. F. Hoffmann-La Roche Ltd; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Pfizer Inc.; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Ophthalmology Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Ophthalmology Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Ophthalmology Drugs Market Customer Information;
5. Ophthalmology Drugs Market Segmentation;
5.1. Global Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 5.2. Global Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Ophthalmology Drugs Market Trends And Strategies;
6. Ophthalmology Drugs Market Regional And Country Analysis;
6.1. Global Ophthalmology Drugs Market, 2016, By Region; 6.2. Global Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Ophthalmology Drugs Market, 2016, By Country; 6.4. Ophthalmology Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors;
7.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Ophthalmology Drugs Expenditure, Global;
8. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Ophthalmology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Ophthalmology Drugs Expenditure, By Country;
9. Ophthalmology Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Glaucoma, 2014, By Country;
10. Asia-Pacific Ophthalmology Drugs Market;
10.1.1. Asia-Pacific Ophthalmology Drugs Market Overview; 10.1.2. Asia-Pacific Ophthalmology Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.2. Asia-Pacific Ophthalmology Drugs Market: Country Analysis; 10.3. China Ophthalmology Drugs Market; 10.3.1. China Ophthalmology Drugs Market Overview; 10.3.2. China Ophthalmology Drugs Historic Market, 2012 - 2016; 10.3.3. China Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.3.4. China Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.3.5. China Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 10.4. India Ophthalmology Drugs Market; 10.4.1. India Ophthalmology Drugs Market Overview; 10.4.2. India Ophthalmology Drugs Historic Market, 2012 - 2016; 10.4.3. India Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.4.4. India Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.4.5. India Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 10.5. Japan Ophthalmology Drugs Market; 10.5.1. Japan Ophthalmology Drugs Market Overview; 10.5.2. Japan Ophthalmology Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.5.5. Japan Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 10.6. Australia Ophthalmology Drugs Market; 10.6.1. Australia Ophthalmology Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Ophthalmology Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.6.4. Australia Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
11. Western Europe Ophthalmology Drugs Market;
11.1.1. Western Europe Ophthalmology Drugs Market Overview; 11.1.2. Western Europe Ophthalmology Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.2. Western Europe Ophthalmology Drugs Market: Country Analysis; 11.3. UK Ophthalmology Drugs Market; 11.3.1. UK Ophthalmology Drugs Market Overview; 11.3.2. UK Ophthalmology Drugs Historic Market, 2012 - 2016; 11.3.3. UK Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.3.5. UK Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.4. Germany Ophthalmology Drugs Market; 11.4.1. Germany Ophthalmology Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.4.4 Germany Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.5 France Ophthalmology Drugs Market; 11.5.1 France Ophthalmology Drugs Historic Market, 2012 - 2016; 11.5.2 France Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.5.3 France Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.5.4 France Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.6. Italy Ophthalmology Drugs Market; 11.6.1. Italy Ophthalmology Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.6.4. Italy Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020; 11.7. Spain Ophthalmology Drugs Market; 11.7.1. Spain Ophthalmology Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Ophthalmology Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.7.4. Spain Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Ophthalmology Drugs Market;
12.1.1. Eastern Europe Ophthalmology Drugs Market Overview; 12.1.2. Eastern Europe Ophthalmology Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Ophthalmology Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.2. Eastern Europe Ophthalmology Drugs Market: Country Analysis; 12.3. Russia Ophthalmology Drugs Market; 12.3.1. Russia Ophthalmology Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Ophthalmology Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.3.4. Russia Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
13. North America Ophthalmology Drugs Market;
13.1.1. North America Ophthalmology Drugs Market Overview; 13.1.2. North America Ophthalmology Drugs Historic Market, 2012 - 2016; 13.1.3. North America Ophthalmology Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.2. North America Ophthalmology Drugs Market: Country Analysis; 13.3. USA Ophthalmology Drugs Market; 13.3.1. USA Ophthalmology Drugs Historic Market, 2012 - 2016; 13.3.2. USA Ophthalmology Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.3.4. USA Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
14. South America Ophthalmology Drugs Market;
14.1.1. South America Ophthalmology Drugs Market Overview; 14.1.2. South America Ophthalmology Drugs Historic Market, 2012 - 2016; 14.1.3. South America Ophthalmology Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.2. South America Ophthalmology Drugs Market: Country Analysis; 14.3. Brazil Ophthalmology Drugs Market; 14.3.1. Brazil Ophthalmology Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Ophthalmology Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.3.4. Brazil Ophthalmology Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012 - 2020;
15. Middle East Ophthalmology Drugs Market;
15.1.1. Middle East Ophthalmology Drugs Market Overview; 15.1.2. Middle East Ophthalmology Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Ophthalmology Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);
16. Africa Ophthalmology Drugs Market;
16.1.1. Africa Ophthalmology Drugs Market Overview; 16.1.2. Africa Ophthalmology Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Ophthalmology Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);
17. Ophthalmology Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Novartis Ag; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Regeneron; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Allergan; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. F. Hoffmann-La Roche Ltd; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Pfizer Inc.; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Ophthalmology Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
